Single-Use Bioprocessing Market worth $ 84.12 Bn by 2030 at a CAGR of 16.1%

July 17, 2022

According Nova one advisor, the global Single-Use Bioprocessing market is valued at US$ 21.98 billion in 2021 and it is expected to grow at a CAGR of 16.1% during the forecast period (2022-2030) The demand in the Single-Use Bioprocessing market is projected to reach a valuation of US$ 84.12 billion by the end of 2030.

Full Report is Ready | Request Free Sample of This Report@ https://www.novaoneadvisor.com/report/sample/6115

 Single-Use Bioprocessing Market

The adoption rate and demand for single-use equipment have significantly increased in the past few years. This is due to the commercial advantages including cost and time-saving advantages associated with it, thereby driving the market.

The growing adoption of the equipment by in-house as well as contract biomanufacturers has spurred the investment flow in this space. Also, the market is witnessing notable advancements in various product portfolios such as stirring systems, bioreactor designs, disposable probes and sensors, and film technologies, thereby leading to strong revenue growth. Furthermore, the implementation of big data and machine-learning technologies exhibits great potential in advancing single-use-based biomanufacturing processes.

Several manufactures have begun shifting towards automation to ease the process and reduce cost margin. Besides, considering the improved efficiency of disposables in accelerating the biopharmaceuticals production, end-users are undertaking various initiatives to convert their bioprocessing unit into a single-use unit. This is anticipated to create lucrative opportunities for the operating technology and product supplier in the market during the forecast period.

Report Scope of the Single Use Bioprocessing Market

Report Coverage Details
Market Size USD 84.12 Billion by 2030
Growth Rate CAGR of 16.1% From 2022 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product, End User, Application, Workflow, Region

 

Single-use Bioprocessing Market Report Highlights

  • The simple and peripheral elements segment accounted for the largest revenue share in 2021 due to diversification of products as well as their frequent usage
  • For instance, disposable probes and sensors are witnessing robust growth in terms of adoption within the biopharmaceutical industry, thereby driving the segment
  • Furthermore, the introduction of single-use bags integrated with adapters, automation, tubing, ports, connectors, and sensors have attributed to the significant share of this segment
  • The apparatus and plants segment is anticipated to grow at a significant pace owing to the expanding applications of products offered in this segment
  • The flexibility offered by single-use bioreactor technology is one of the key factors driving investment in the segment
  • Furthermore, the presence of a wide array of products for both upstream and downstream processing has resulted in the large revenue share of this segment
  • Biopharmaceutical manufacturers are estimated as the largest key end-users of the market
  • Facility expansion and increasing adoption of disposables by contract manufacturing organizations is playing a vital role in accelerating the biopharmaceutical manufacturing industry
  • North America dominated the market owing to the presence of strong research as well as the commercial base for biopharmaceutical manufacturing
  • Moreover, the U.S. is the largest biopharmaceutical market that has positively influenced the adoption of single-use technologies in the region
  • The shifting focus of U.S.-based companies from conventional manufacturing practices to disposable manufacturing systems also drives regional growth
  • Asia Pacific is estimated to witness the fastest growth with emerging markets such as China and Japan at the forefront
  • Collaborations between domestic and global players for expansion of biomanufacturing capabilities is driving the market in the Asia Pacific
  • Key companies are focusing on new product launches to sustain their position in the market

Full Report is Ready | Quick Buy This Premium Report from Here@ https://www.novaoneadvisor.com/report/checkout/6115

Regional Snapshots

North America is the leading single-use bioprocessing market owing to the increased spending on healthcare, technological development in bioprocessing, and growing importance of life science research. Growing adoption of disposable systems and increased energy efficiency coupled with the minimal risk of product cross-contamination are the beneficial factors associated with the use of single-use bioprocessing products. Further, the introduction of automation, big data technology, and artificial intelligence in the single-use system has been gaining rapid traction in North America. These latest technologies in the manufacturing units are expected to boost production and helps the manufacturers to achieve cost-efficiency and reduce wastages.The presence of a large number of big and small contract manufacturing organizations in the region are increasingly using the single-use bioprocessing technology due to its low cost and improved output. The increased economic activity of these contract manufacturers will significantly drive the growth of the single-use bioprocessing market in North America.

Asia Pacific is characterized by growing production of biosimilars, cell therapy, vaccines, and various other types of biopharmaceutical products. Moreover, China is the second largest biopharmaceutical market just after the US. China’s economic policies to attract FDIs for setting up manufacturing plants for biopharmaceutical products is exponentially fostering the demand for single-use bioprocessing technology. Moreover, nations like India, Japan, and South Korea have been a leading player in the Asia Pacific region. Biocon of India and Samsung Biologics of South Korea have earned FDA and European Medicines Agency approval respectively, for their new biosimilar products in 2017. Therefore, the single-use bioprocessing market has huge growth potential in the Asia Pacific region.

Some of the prominent players in the Single-Use Bioprocessing market include:

  • Thermo Fisher Scientific, Inc.
  • Sartorius AG
  • Merck KGaA
  • Pall Corporation
  • Corning Incorporated
  • Eppendorf AG
  • General Electric Company (GE Healthcare)
  • Lonza
  • Rentschler Biopharma SE
  • JM BioConnect
  • Meissner Filtration Products, Inc.
  • Infors AG
  • BoehringerIngelheim GmbH
  • Entegris, Inc.
  • PBS Biotech, Inc.

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:

Segments Covered in the Report

By Product

  • Filtration Assemblies
  • Disposable Bioreactors
  • Disposable Mixers
  • Media Bags & Containers
  • Others

By Application

  • Filtration
  • Purification
  • Cell Culture
  • Others

By End User

  • Biopharmaceutical Manufacturers
  • Clinical & Academic Research Institutes
  • Others

By Workflow

  • Upstream
  • Fermentation
  • Downstream

Click Here to View Full Report Table of Contents

Full Report is Ready | Quick Buy This Premium Report From Here@ https://www.novaoneadvisor.com/report/checkout/6115

 About Us

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333